[go: up one dir, main page]

WO2023022672A3 - Process for the preparation of homogeneous suspensions for the inhalation by nebulization - Google Patents

Process for the preparation of homogeneous suspensions for the inhalation by nebulization Download PDF

Info

Publication number
WO2023022672A3
WO2023022672A3 PCT/TR2021/050827 TR2021050827W WO2023022672A3 WO 2023022672 A3 WO2023022672 A3 WO 2023022672A3 TR 2021050827 W TR2021050827 W TR 2021050827W WO 2023022672 A3 WO2023022672 A3 WO 2023022672A3
Authority
WO
WIPO (PCT)
Prior art keywords
inhalation
nebulization
preparation
homogeneous suspensions
ivermectin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/TR2021/050827
Other languages
French (fr)
Other versions
WO2023022672A2 (en
Inventor
Devrim Celik
Emine Yilmaz
Yelda EKRAM
Gokce Canan TASKIN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Arven Ilac Sanayi ve Ticaret AS
Original Assignee
Arven Ilac Sanayi ve Ticaret AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arven Ilac Sanayi ve Ticaret AS filed Critical Arven Ilac Sanayi ve Ticaret AS
Priority to PCT/TR2021/050827 priority Critical patent/WO2023022672A2/en
Publication of WO2023022672A2 publication Critical patent/WO2023022672A2/en
Publication of WO2023022672A3 publication Critical patent/WO2023022672A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention relates to a simple, rapid, cost effective, time-saving and industrially convenient process for the preparation of suspensions to be used in pharmaceutical formulations comprising ivermectin as an active agent for inhalation by nebulization. Further, the present invention also relates to inhalation compositions comprising ivermectin, isotonic agents, buffering agents, dispersing or suspending agents.
PCT/TR2021/050827 2021-08-18 2021-08-18 Process for the preparation of homogeneous suspensions for the inhalation by nebulization Ceased WO2023022672A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/TR2021/050827 WO2023022672A2 (en) 2021-08-18 2021-08-18 Process for the preparation of homogeneous suspensions for the inhalation by nebulization

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/TR2021/050827 WO2023022672A2 (en) 2021-08-18 2021-08-18 Process for the preparation of homogeneous suspensions for the inhalation by nebulization

Publications (2)

Publication Number Publication Date
WO2023022672A2 WO2023022672A2 (en) 2023-02-23
WO2023022672A3 true WO2023022672A3 (en) 2023-04-20

Family

ID=85241145

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/TR2021/050827 Ceased WO2023022672A2 (en) 2021-08-18 2021-08-18 Process for the preparation of homogeneous suspensions for the inhalation by nebulization

Country Status (1)

Country Link
WO (1) WO2023022672A2 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003086347A1 (en) * 2002-04-17 2003-10-23 Chiesi Farmaceutici S.P.A. Process for preparation of a sterile suspension of corticosteroid particles for the administration by inhalation

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003086347A1 (en) * 2002-04-17 2003-10-23 Chiesi Farmaceutici S.P.A. Process for preparation of a sterile suspension of corticosteroid particles for the administration by inhalation

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CHACCOUR CARLOS, ABIZANDA GLORIA, IRIGOYEN-BARRIO ÁNGEL, CASELLAS AINA, ALDAZ AZUCENA, MARTÍNEZ-GALÁN FERNANDO, HAMMANN FELIX, GIL: "Nebulized ivermectin for COVID-19 and other respiratory diseases, a proof of concept, dose-ranging study in rats", SCIENTIFIC REPORTS, vol. 10, 1 December 2020 (2020-12-01), pages 1 - 11, XP055963474, DOI: 10.1038/s41598-020-74084-y *
EEDARA BASANTH BABU, ALABSI WAFAA, ENCINAS-BASURTO DAVID, POLT ROBIN, LEDFORD JULIE G., MANSOUR HEIDI M.: "Inhalation Delivery for the Treatment and Prevention of COVID-19 Infection", PHARMACEUTICS, vol. 13, no. 7, pages 1 - 24, XP093063652, DOI: 10.3390/pharmaceutics13071077 *

Also Published As

Publication number Publication date
WO2023022672A2 (en) 2023-02-23

Similar Documents

Publication Publication Date Title
MY202837A (en) Lipids for lipid nanoparticle delivery of active agents
WO2009050726A3 (en) Compositions and methods for improved delivery of bupropion
CA3242399A1 (en) Fluorinated cationic lipids for use in lipid nanoparticles
PL199782B1 (en) Compositions for prevention and treatment of cold and influenza−like symptoms and their methods of use
MX2022012359A (en) Formulation.
WO2024054843A3 (en) Lipids for use in lipid nanoparticle formulations
BRPI0608291A2 (en) immunosuppressive agent and antitumor agent comprising heterocyclic compound as active ingredient
WO2007090822A3 (en) Pharmaceutical formulation for aerosols, comprising two or more active agents and at least one surfactant
CA2554975A1 (en) Methods of preventing and treating sars using low ph respiratory tract compositions
JP2009544665A5 (en)
EP1583559B1 (en) Compositions for prevention and treatment of cold and influenza-like symptoms comprising select mucoadhesive polymers
JP2013535472A5 (en)
JP7509370B2 (en) Antiviral agent and method for removing viruses
WO2024076951A3 (en) Antiviral prodrugs and formulations thereof
MY191712A (en) Composition comprising at least one dry powder obtained by spray drying to increase the stability of the formulation
WO2022240379A3 (en) A stable pharmaceutical composition comprising selexipag
MX2025005209A (en) Lipid compounds and uses thereof
JP2016188259A (en) Aqueous ophthalmic composition
CN1063914C (en) Plant protection pesticide containing avermectin
WO2023022672A3 (en) Process for the preparation of homogeneous suspensions for the inhalation by nebulization
HUP0301506A2 (en) Pharmaceutical compositions for the treatment of painful, inflammatory and ulcerative conditions of moist epithelial surfaces such as mucositis, stomatitis and behcet's syndrome
JP2014534215A5 (en)
AU2014226192A8 (en) Dry pharmaceutical compositions comprising active agent nanoparticles bound to carrier particles
IL163608A (en) Amino/imino-substituted sulfonanilides and derivatives thereof, process for the preparation thereof, pharmaceutical compositions and antibody conjugates comprising them and use thereof in the preparation of medicaments for treating proliferative disorders
WO2004033479A3 (en) Retroyclins: antiviral and antimicrobial peptides

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 21954371

Country of ref document: EP

Kind code of ref document: A2